论文部分内容阅读
我科自1980年3月—1984年5月共收治蛛网膜下腔出血(SAH)80例,占同期住院急性脑血管疾病940例的8.5％,仅次于脑梗塞和脑出血,居急性脑血管病的第三位。SAH急性期的再出血及死亡率均较高,为观察6-氨基己酸(EACA)对SAH的疗效,我们自1980年3月以来,对73例SAH病例除内科常规治疗外无选择地选用EACA治疗,现将观察结果报告如下: 一、临床资料:
Our department from March 1980 to May 1984 were treated 80 cases of subarachnoid hemorrhage (SAH), accounting for 8.5% of 940 cases of hospitalized acute cerebrovascular disease in the same period, second only to cerebral infarction and cerebral hemorrhage, ranking the acute brain The third of vascular disease. SAH in the acute phase of rebleeding and mortality were higher, in order to observe the efficacy of 6-aminocaproic acid (EACA) on SAH, we have since March 1980, 73 cases of SAH cases, except for conventional treatment of internal medicine, no choice EACA treatment, the observation results are reported as follows: First, the clinical data: